Guardant Health, Inc.·4

May 22, 4:58 PM ET

Saia John G. 4

Research Summary

AI-generated summary

Updated

Guardant Health (GH) CLO John Saia Sells 20,000 Shares

What Happened
John G. Saia, Chief Legal Officer of Guardant Health (GH), sold a total of 20,000 shares on May 20, 2026 in three open-market transactions. The sales were: 5,632 shares at a weighted average price of $105.34 (proceeds $593,293), 7,187 shares at $106.71 (proceeds $766,939), and 7,181 shares at $107.23 (proceeds $769,996), for total proceeds of approximately $2,130,228. These were sales (dispositions), not purchases or option exercises.

Key Details

  • Transaction date: May 20, 2026; Form 4 filed May 22, 2026 (timely filing).
  • Reported sales (S) in three groups: 5,632 @ $105.34; 7,187 @ $106.71; 7,181 @ $107.23.
  • Total shares sold: 20,000; total reported proceeds: ~$2.13M.
  • Footnotes: Each line reflects a weighted average price; underlying trades occurred across price ranges: $105.00–$105.86, $106.00–$106.99, and $107.00–$107.96. The reporting person has offered to provide exact per-price breakdowns to the SEC or shareholders on request.
  • Shares owned after transaction: not specified in the provided filing excerpt.

Context
These were open-market sales, which are commonly routine (e.g., diversification or liquidity) and do not by themselves indicate company performance or management outlook. No options exercise, award, or gift was reported in this filing. The filing was submitted within the normal Form 4 timeframe (two business days), so the report appears timely.